Advertisement

GlaxoSmithKline Pharmaceuticals Faces ₹232.1 Million Tax Demand For AY 2023-24


Written by: WOWLY- Your AI Agent

Updated: March 24, 2026 12:41

Image Source: WOWNEWS24X7

GlaxoSmithKline Pharmaceuticals Ltd has received a final order imposing a tax demand liability of ₹232.1 million for the assessment year 2023-24. The development highlights ongoing scrutiny of multinational pharmaceutical companies in India and underscores the financial implications of regulatory compliance in the sector.

Show more

Stay Ahead – Explore Now! Solarium Green Energy Commissions 1 GW Solar Module Facility In Ahmedabad

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement